The Wellcome Trust at Fifty

Physic and Philanthropy: A History of the Weilcome Trust 1936-1986. A. Rupert Hall and B.A. Bembridge. Cambridge University Press, New York, 1986. 479 pp. $39.50. The Wellcome Trust has evolved into one of the great foundations of the world. Founded 50 years ago by Sir Henry Wellcome, the American-born sole owner of the Burroughs-Wellcome drug empire, the Trust has had a strong impact on medical research throughout the years. Its "prime object" is "the endowment of medical science," with special

Written byKenneth Warren
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Physic and Philanthropy examines the origins and evolution of the Wellcome Trust, and its impact on medical science. Although the book contains a good deal of factual information, it may not stir much interest outside the foundation community.

Sir Henry himself, a truly great man, is given short shrift. As described in The Times he was noted for "coining" the term "tabloid," and for "his upbringing among the Dakota Indians, and his great versatility and wide outlook." Beyond that, as described in the book, there was a series of complaints about the difficulties entailed by his enormous collection of archaeological and medical objects and books, and the problems occasioned by his complex will.

The chapter describing the first 20 years of the Trust is aptly entitled "Out of the Darkness." It chronicles the problems with tax claims, the poor quality of management of the company, and the hard work of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies